$ガレラ セラピューティクス(GRTX.US)$Galera reported a net loss of $(4.4) million, or $(0.08) per share, for the first quarter of 2024, compared to a net loss of $(17.7) million, or $(0.50) per share, for the same period in 2023.
Trytosaveabitスレ主Jaguar8:
I know right! Before they got the CRL late last year they were trading above 2.00! They should be back up over that? Grrr hehehe
Trytosaveabitスレ主买跌不追涨:
And I don’t expect to see much? Maybe a bit during RMH? But I’m also looking for it to maybe start a overall uptrend eventually? NFA JMO! GL
$ガレラ セラピューティクス(GRTX.US)$10% Shareholder Schneid Yair purchased 2.78 million shares of common stock on Apr 17, 2014 and Apr 17, 18, 19, 2024 at an average price of $0.2124 for a total value of $590.42K.
$ガレラ セラピューティクス(GRTX.US)$Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.35) by 71.43 percent. This is a 82.76 percent increase over losses of $(0.58) per share from the same period last year.
1
2
報告
Trytosaveabitスレ主 :
As Of December 31, 2023, Galera Had Cash And Cash Equivalents Of $18.3M Which Is Expected To Provide Cash Runway Into Q2 Of 2025
Galera Therapeutics Insider Purchase: A Strategic Move or a Signal of Confidence? Galera Therapeutics Inc. (NASDAQ: GRTX), a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for transformational improvements in cancer treatment, has recently seen a significant insider purchase. Yair Schneid, 10% owner of Galera, bought 932.4k shares at $0.18 each. This move is intriguing and deserves...
Jaguar8 : Huge EPS improvement
Trytosaveabitスレ主 Jaguar8: I know right! Before they got the CRL late last year they were trading above 2.00! They should be back up over that? Grrr hehehe
Jaguar8 Trytosaveabitスレ主: Hopefully
买跌不追涨 : 股价无反应
Trytosaveabitスレ主 买跌不追涨: And I don’t expect to see much? Maybe a bit during RMH? But I’m also looking for it to maybe start a overall uptrend eventually? NFA JMO! GL
もっとコメントを見る...